高流量氧疗或无创通气时ARDS标准的局限性:来自危重型COVID-19患者的证据
这项单中心前瞻性观察研究纳入瑞典乌普萨拉大学医院ICU的148例危重型COVID-19患者,在稳态下记录HFNC、NIV与MV之间切换前后的PaO2/FIO2。任何涉及HFNC的切换均引起PaO2/FIO2显著变化,而NIV与MV之间的切换未见一致变化。MV下判为轻中度ARDS的患者,从HFNC转为MV时PaO2/FIO2升高幅度在52至140 mmHg之间(中位数127 mmHg),使由HFNC下的表观ARDS分级预测MV下ARDS严重程度不可能。作者认为HFNC下估测ARDS分级作为肺损伤指标时应非常谨慎。
要点
- 同一患者中,任何涉及HFNC的呼吸支持切换(从或至HFNC)均引起PaO2/FIO2显著变化,而NIV与MV之间切换未见一致变化。
- MV下判为轻中度ARDS的患者,从HFNC转为MV时PaO2/FIO2升高幅度为52至140 mmHg(中位数127 mmHg),个体差异大。
- 由HFNC下的表观ARDS分级预测MV下的ARDS严重程度不可能。
- 作者认为,在HFNC期间将ARDS分级作为肺损伤程度的估计指标时应非常谨慎。
适用人群与场景
- 瑞典乌普萨拉大学医院ICU收治的危重型COVID-19患者,单中心前瞻性观察研究,共148例纳入本分析。
- 在稳态条件下,于HFNC、NIV和MV三种呼吸支持技术之间任何切换前后记录PaO2/FIO2。
研究设计与关键结果
- 研究类型:单中心前瞻性观察研究;人群:ICU危重型COVID-19患者;样本量:148例。
- 任何涉及HFNC的呼吸支持切换(从或至HFNC)均引起PaO2/FIO2显著变化;NIV与MV之间切换未见PaO2/FIO2的一致变化。
- MV下判为轻中度ARDS的患者,从HFNC转为MV时PaO2/FIO2升高幅度在52至140 mmHg之间(中位数127 mmHg)。
- 由HFNC下的表观ARDS分级预测MV下的ARDS严重程度不可能。
- HFNC与同一患者NIV或MV时相比PaO2/FIO2更低;NIV与MV提供的PaO2/FIO2相似,因而按柏林定义的ARDS分级相似。
证据类型、等级与局限
- 证据类型:单中心前瞻性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,HFNC期间PaO2/FIO2低于NIV或MV,HFNC下估测的ARDS分级不能用于预测MV下的ARDS严重程度,将ARDS分级作为HFNC期间肺损伤程度的指标时应非常谨慎。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The ratio of partial pressure of arterial oxygen to inspired oxygen fraction (PaO2/FIO2) during invasive mechanical ventilation (MV) is used as criteria to grade the severity of respiratory failure in acute respiratory distress syndrome (ARDS). During the SARS-CoV2 pandemic, the use of PaO2/FIO2 ratio has been increasingly used in non-invasive respiratory support such as high-flow nasal cannula (HFNC) and non-invasive ventilation (NIV). The grading of hypoxemia in non-invasively ventilated patients is uncertain. The main hypothesis, investigated in this study, was that the PaO2/FIO2 ratio does not change when switching between MV, NIV and HFNC.
METHODS: We investigated respiratory function in critically ill patients with COVID-19 included in a single-center prospective observational study of patients admitted to the intensive care unit (ICU) at Uppsala University Hospital in Sweden. In a steady state condition, the PaO2/FIO2 ratio was recorded before and after any change between two of the studied respiratory support techniques (i.e., HFNC, NIV and MV).
RESULTS: A total of 148 patients were included in the present analysis. We find that any change in respiratory support from or to HFNC caused a significant change in PaO2/FIO2 ratio. Changes in respiratory support between NIV and MV did not show consistent change in PaO2/FIO2 ratio. In patients classified as mild to moderate ARDS during MV, the change from HFNC to MV showed a variable increase in PaO2/FIO2 ratio ranging between 52 and 140 mmHg (median of 127 mmHg). This made prediction of ARDS severity during MV from the apparent ARDS grade during HFNC impossible.
CONCLUSIONS: HFNC is associated with lower PaO2/FIO2 ratio than either NIV or MV in the same patient, while NIV and MV provided similar PaO2/FIO2 and thus ARDS grade by Berlin definition. The large variation of PaO2/FIO2 ratio indicates that great caution should be used when estimating ARDS grade as a measure of pulmonary damage during HFNC.
参考来源
- Hultström M, Hellkvist O, Covaciu L, et al. Limitations of the ARDS criteria during high-flow oxygen or non-invasive ventilation: evidence from critically ill COVID-19 patients. Crit Care. 2022. PMID: 35255949. doi:10.1186/s13054-022-03933-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。